United States · 
What does Owl Rock Capital invest in?
Owl Rock Capital invests most often at Series C and Series E (100% of the rounds on record).
Owl Rock Capital highlights
- 01
2 rounds on record
- 02
Mostly Series C and Series E: 100% of its rounds
What they do
- Type
- Private equity (from a list, unverified)
- Cheque size
- $10K – $50K as they say
- Stages
- SeedSeries ASeries BGrowthPre-IPO
- Based in
- New York, NY, United States
- Cold pitches
- Not stated
The record
Every round we can evidence, newest first2 appearances
- 2019
2 rounds
- Oct
- Jul
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
The team
Named by the firm itself, on a filing, its Form ADV or its company registration17 named
AKAlan KirshenbaumExecutive Officer, DirectoriFiling they signed
AWAlexis W. MagedExecutive OfficeriFiling they signed
BWBrian W. FinnDirectoriFiling they signed
BWBryan W. ColeExecutive OfficeriFiling they signed
CTChristopher TempleDirectoriFiling they signed
CWCraig W. PackerPresident and Chief Executive OfficeriFiling they signed
DWDouglas W. OstroverExecutive Officer, DirectoriFiling they signed
EDEdward D'AlelioDirectoriFiling they signed
EKEric KayeDirectoriFiling they signed
JMJennifer McMillonExecutive OfficeriFiling they signed
KHKaren HagerExecutive OfficeriFiling they signed
MSMatthew SwattExecutive OfficeriFiling they signed
MWMelissa WeilerDirectoriFiling they signed
NRNeena ReddyExecutive OfficeriFiling they signed
RTRebecca TabbExecutive OfficeriFiling they signed
SWShari WithemExecutive OfficeriFiling they signed
VWVictor WoolridgeDirectoriFiling they signed
We also hold 16 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.
What they claim to have backed
From their own portfolio page (on their website)
0 of 3 we have independently watched raise
BlueowlproductsQuoteMediaRSS feed
Weaker than a round we watched, stronger than a list somebody sold us. A firm is far less willing to put a company on its own site that it never funded.